Prison hepatitis c study pulled before it began
NCT ID NCT05649202
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to see if faster testing and treatment for hepatitis C could be given to inmates right when they enter prison. The goal was to start medication sooner to reduce the spread of the virus. However, the study was withdrawn and no one took part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Expected to start
-
Jan 2023
An estimate. Start dates often move.
- Expected to finish
-
Jul 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Persons detained at the Paris-La Santé Penitentiary Center (CPPLS) from the state of liberty or transferred from another prison who have a positive HCV serology
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patient (\>/= 18 years old), * Persons detained at the Paris-La Santé Penitentiary Center (CPPLS) coming from the state of freedom or transferred from another penitentiary establishment * Serology HCV positive Exclusion Criteria: * Major psychiatric disorders with loss of discernment * Persons under guardianship or curatorship * Persons not affiliated to a social security scheme
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic hepatitis C virus infection are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Internal Medicine Service, Cochin Hospital (Consultation and Ambulatory Care Unit (UCSA) within the Paris-La Santé Penitentiary Center (CPPLS))
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a digital platform catch liver cancer sooner?
- Blood scores may identify low-risk patients after hepatitis c cure, reducing need for lifelong cancer scans
- On-the-Spot hep c care at methadone clinics boosts cure rates
- French study maps hepatitis c subtypes to improve treatment
- New blood test could spot liver cancer sooner
- New HIV vaccine trial aims to spark rare antibodies that could fight the virus